Skip to main content
BLCO
NYSE Life Sciences

BL1332 Phase 2 Misses Primary Endpoint, Clouding Path to Phase 3

Tom Rudovsky · Reported by Wiseek News
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$20.51
Mkt Cap
$7.397B
52W Low
$14.44
52W High
$21.4
52W Position info
42% above low
Off High info
4.2% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

BLCO sits 42% above its 52-week low of $14.44.

Summary

Bausch + Lomb's Phase 2 BL1332 trial in 129 post-surgical patients failed to hit its primary endpoint. Both doses produced numerically greater pain relief than vehicle — LS mean differences of -11.5 and -9.0 — but neither reached statistical significance on the primary measure. The 0.30% dose was nominally significant at six hours and complete relief rates at that point were 14.0% and 14.6% versus 3.7% for vehicle, though these are secondary and exploratory findings, not confirmatory evidence. Adverse event rates were 6.0%, 13.7% and 14.8% for the 0.30%, 0.15% and vehicle arms, with no treatment-related or serious events reported. The company says it will discuss the results with the FDA and is still evaluating Phase 3 planning, with no commitment announced — so the program's future is unresolved. This lands with the stock near its 52-week high, leaving little room for a clinical setback.

At the time of this announcement, BLCO was trading at $20.51 on NYSE in the Life Sciences sector, with a market capitalization of approximately $7.4B. The 52-week trading range was $14.44 to $21.40. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

BLCO - Latest Insights

BLCO
Oct 28, 2026, 4:25 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $20.08
Real-time Price: $20.38 info
Change: +$0.3041 (+2%) info
Market Cap: $7.397B info
BLCO
Oct 28, 2026, 7:03 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $18.25
Real-time Price: $20.38 info
Change: +$2.13 (+12%) info
Market Cap: $7.397B info
BLCO
Oct 28, 2026, 6:58 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $17.43
Real-time Price: $20.38 info
Change: +$2.95 (+17%) info
Market Cap: $7.397B info
BLCO
Oct 13, 2026, 6:09 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $16.07
Real-time Price: $20.38 info
Change: +$4.31 (+27%) info
Market Cap: $7.397B info
BLCO
Oct 12, 2026, 7:35 AM EDT
Source: Seeking Alpha
Importance Score:
8
Price at Filing: $17.30
Real-time Price: $20.38 info
Change: +$3.08 (+18%) info
Market Cap: $7.397B info